Two Sigma Advisers’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79M | Buy |
224,300
+41,000
| +22% | +$1.79M | 0.02% | 509 |
|
|
2025
Q1 | $5.02M | Sell |
183,300
-77,000
| -30% | -$2.11M | 0.01% | 791 |
|
|
2024
Q4 | $10.5M | Sell |
260,300
-76,000
| -23% | -$3.06M | 0.02% | 473 |
|
|
2024
Q3 | $15.9M | Sell |
336,300
-30,700
| -8% | -$1.45M | 0.04% | 368 |
|
|
2024
Q2 | $11M | Buy |
367,000
+157,900
| +76% | +$4.71M | 0.02% | 512 |
|
|
2024
Q1 | $8.41M | Buy |
209,100
+38,200
| +22% | +$1.54M | 0.02% | 590 |
|
|
2023
Q4 | $4.35M | Sell |
170,900
-17,600
| -9% | -$448K | 0.01% | 876 |
|
|
2023
Q3 | $2.62M | Buy |
188,500
+25,900
| +16% | +$360K | 0.01% | 1051 |
|
|
2023
Q2 | $3.74M | Sell |
162,600
-39,500
| -20% | -$908K | 0.01% | 890 |
|
|
2023
Q1 | $5.99M | Buy |
202,100
+18,800
| +10% | +$557K | 0.02% | 738 |
|
|
2022
Q4 | $4.58M | Buy |
183,300
+5,300
| +3% | +$132K | 0.01% | 820 |
|
|
2022
Q3 | $3.88M | Sell |
178,000
-53,700
| -23% | -$1.17M | 0.01% | 868 |
|
|
2022
Q2 | $4.56M | Buy |
231,700
+204,900
| +765% | +$4.03M | 0.01% | 816 |
|
|
2022
Q1 | $1.13M | Buy |
26,800
+21,400
| +396% | +$906K | ﹤0.01% | 1575 |
|
|
2021
Q4 | $343K | Buy |
+5,400
| New | +$343K | ﹤0.01% | 2091 |
|